Situaci車n del c芍ncer en Espa a: incidencia State of cancer in Spain: incidence

作者：G Lopez Abente; M Pollan; N Aragones; B Perez Gomez

来源：Anales del Sistema Sanitario de Navarra, 2004.

• Cancer
• Epidemiologia
• Mortalidad
• Incidencia
• Cancer
• Epidemiology
• Mortality
• Incidence

Se estima que actualmente se diagnostican en Espa a unos 162.000 casos de c芍ncer al a o (sin contar el c芍ncer de piel no-melanoma) de los que 25.600 corresponden a carcinomas colorrectales, que es el tumor m芍s frecuente de todos en t谷rminos absolutos. El siguiente tumor en frecuencia es el c芍ncer de pulm車n con 18.800 casos nuevos, seguido del c芍ncer de mama en mujeres con 15.979 casos. Cuando se compara la incidencia de c芍ncer con la de los pa赤ses de nuestro entorno, en hombres Espa a presenta unas tasas ajustadas superiores a las del promedio de la UE, ocupando el 5o lugar. Sin embargo, en mujeres, Espa a muestra las tasas de incidencia m芍s bajas junto con Grecia. Para el c芍ncer de vejiga en hombres, Espa a ocupa el primer lugar, con tasas bastante superiores a las del resto de pa赤ses. Es importante constatar el incremento que est芍 sufriendo la incidencia de c芍ncer en Espa a y el contraste que supone frente a la evoluci車n de la mortalidad. Para muchas localizaciones tumorales importantes (pulm車n, est車mago, vejiga), los registros poblacionales no cubren las provincias con una mayor mortalidad. It is estimated that at present in Spain around 162,000 cases of cancer are diagnosed each year (without including non-melanoma skin cancer), of which 25,600 correspond to colorectal carcinomas, which is the most frequent of all tumours in absolute terms. The next tumour in terms of frequency is lung cancer with 18,800 new cases, followed by breast cancer in women with 15,979 cases. When the incidence of cancer is compared with that in neighbouring countries, Spain shows adjusted rates in men higher than those of the average for the EU, occupying the 5th place. However, in women, Spain shows the lowest rates together with Greece. Spain occupies the first place for cancer of the bladder in men, with rates that are considerably higher than those of the rest of the countries. It is important to verify the increase underway in the incidence of cancer in Spain and the contrast that this represents facing the evolution of mortality. For many important tumoral localisations (lung, stomach, bladder), the population registers do not cover the provinces where there is a greater mortality.